Kamada VP granted 22,500 and 90,000 stock options

The options vest in four equal installments, while their exercise prices were adjusted in connection with a special cash dividend.

Rhea-AI Filing Summary

KAMADA LTD VP, Operations Nir Eran reported two employee stock option awards on August 27, 2026: 22,500 options at a $5.98 exercise price and 90,000 options at a $7.44 exercise price. Both are held by a trustee under the company's 2011 Share Award Plan and vest in four equal installments, with 25% vesting on each grant anniversary. The exercise prices were adjusted in connection with a special cash dividend declared August 17, 2026, with a record date of August 27, 2026. The prices are presented in U.S. dollars based on the Bank of Israel exchange rate as of September 22, 2026; no Rule 10b5-1 plan is reported.

Insider Trade Summary

Grant/Award: 112,500 shares

Grant/Award 2 txns

Insider Nir Eran

Role VP, Operations

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1, F4, F2, F3	22,500	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F1, F5, F2, F3	90,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 112,500 contracts (Indirect, Held by trustee)

Footnotes (5)

1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.
4. F4. This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. F5. This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Key Figures

Employee stock options: 22,500 options Exercise price: $5.98 per share Employee stock options: 90,000 options +3 more

6 metrics

Employee stock options 22,500 options Award dated August 27, 2026; held by a trustee

Exercise price $5.98 per share For the 22,500-option award; presented in USD

Employee stock options 90,000 options Award dated August 27, 2026; held by a trustee

Exercise price $7.44 per share For the 90,000-option award; presented in USD

Vesting installments 4 installments 25% vests on each grant anniversary

Vesting per installment 25% Of each option award on each grant anniversary

Key Terms

Employee Stock Option (right to buy), exercise prices, vest in four equal installments, 2011 Share Award Plan

4 terms

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy)"

exercise prices financial

"The exercise prices of all options reported"

vest in four equal installments financial

"Options vest in four equal installments"

2011 Share Award Plan financial

"under the Company's 2011 Share Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What option awards did KAMADA LTD VP, Operations Nir Eran report?

Nir Eran reported 22,500 options at a $5.98 exercise price and 90,000 options at a $7.44 exercise price, dated August 27, 2026. Both are held by a trustee under the company's 2011 Share Award Plan.

When do the KMDA option awards vest?

The options vest in four equal installments, with 25% vesting on each of the four anniversaries of the grant date.

Why were the KMDA option exercise prices adjusted?

The exercise prices were adjusted in connection with a special cash dividend declared August 17, 2026, with a record date of August 27, 2026. The options were previously reported at $6.15 and $7.61, respectively.

Were the KMDA option awards reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for these option awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 01:32 PM Accepted by SEC EDGAR 09/23/2026 - 01:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nir Eran

(Last) (First) (Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$5.98(1)(4)	08/27/2026		A		22,500		(2)	(2)	Ordinary Shares	22,500	$0.00	22,500	I	Held by trustee(3)
Employee Stock Option (right to buy)	$7.44(1)(5)	08/27/2026		A		90,000		(2)	(2)	Ordinary Shares	90,000	$0.00	90,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

3. Held by trustee under the Company's 2011 Share Award Plan.

4. This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

5. This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

	/s/ Eran Nir	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)